Abstract
Recently, cancer vaccines stand out as a promising strategy capable of inducing a specific and lasting immune response against antigens expressed in tumors,usually aproteins overexpressed and related in tumor progression and metastasis. DNA vaccines become advantageous once they are plasmids designed to deliver genes that encode these antigens, inducing and increasing the adaptive immune …